Drug intelligence / Profile preview

Lactiplantibacillus plantarum Probio87

Development stage: Unknown
Lead developer: Universiti Sains Malaysia
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Lactiplantibacillus plantarum Probio87 is a specific probiotic strain developed and studied by Universiti Sains Malaysia. It is being investigated for its therapeutic potential in managing Human Papillomavirus (HPV) infections. In a randomized, double-blind, placebo-controlled clinical trial (NCT05316064), oral administration of L. plantarum Probio87 at a dose of 9 log CFU/day for 12 weeks was shown to significantly reduce vaginal HPV abundance. [6] The proposed mechanism involves the modulation of both the gut and vaginal microbiome, leading to an increase in beneficial Lactobacillus species and a decrease in pathogenic microbes. [5, 8] This modulation is believed to enhance local immunity, reduce inflammation, and improve the overall quality of life for HPV-positive women. [6]

Other names: probiotic-Universiti Sains Malaysia

Beyond the preview

Go deeper on Lactiplantibacillus plantarum Probio87.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactiplantibacillus plantarum Probio87.

Explore the full profile